What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
oncologist, Dubai
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Isabelle THOMASSIN NAGGARA
Copyright © 2026 - BCU